Appropriateness and limitations of modified Response Evaluation Criteria in Solid Tumors (mRECIST) in evaluating the efficacy of molecular-targeted therapy for patients with hepatocellular carcinoma
2018 ◽
Vol 29
(12)
◽
pp. 1654-1661
◽
2021 ◽
Vol 17
(3)
◽
pp. 707
2012 ◽
Vol 118
(1)
◽
pp. 16-22
◽
2010 ◽
Vol 195
(3)
◽
pp. W221-W228
◽